The Hill -- Al Franken (D-Minn.) shared the medical device industry’s concerns with regulators this week. The senator’s meeting with Food and Drug Administration Commissioner Margaret Hamburg comes as federal regulators are considering more than 70 changes to the 510(k) pre-market review process for low- and moderate-risk devices.
